Women of childbearing potential/Contraception in females: Women of childbearing potential should use effective methods of contraception during use of teriparatide. If pregnancy occurs, Sondelbay should be discontinued.
Pregnancy: Sondelbay is contraindicated for use during pregnancy.
Breast-feeding: Sondelbay is contraindicated for use during breast-feeding. It is not known whether teriparatide is excreted in human milk.
Fertility: Studies in rabbits have shown reproductive toxicity. The effect of teriparatide on human foetal development has not been studied. The potential risk for humans is unknown.
Other Services
Country
Account